logo

NNVC

NanoViricides·AMEX
--
--(--)
--
--(--)
5.28 / 10
Netural

Fundamental assessment is average (5.3/10). Key positives include a solid Interest coverage ratio (42.48) and strong revenue growth (64.39% YoY). Concerns remain over high Days sales outstanding (313.91) and negative Revenue-MV (-0.257). These factors collectively suggest a selective investment case.

Fundamental(5.28)SentimentTechnical

Analysis Checks(9/10)

Revenue-MV
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value45.97
Score2/3
Weight1.48%
1M Return1.11%
Days sales outstanding
Value313.91
Score1/3
Weight-1.90%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
PB-ROE
Value1.18
Score2/3
Weight17.20%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.38%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value64.40
Score2/3
Weight0.57%
1M Return0.43%
Asset-MV
Value-1.88
Score3/3
Weight25.57%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Is NNVC fundamentally strong?
  • NNVC scores 5.28/10 on fundamentals and holds a Fair valuation at present. Backed by its -24.30% ROE, 0.00% net margin, -2.34 P/E ratio, 2.65 P/B ratio, and 34.21% earnings growth, these metrics solidify its Netural investment rating.